Kura Oncology, Inc. | Business Contracts

Loan and Security Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Hercules Capital, Inc (Filed With SEC on November 3, 2022)

Separation Agreement, effective as of February 4, 2022, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on February 24, 2022)

Lease Agreement, dated May 11, 2021, by and between the Registrant and BP3-SD5 5510 Morehouse Drive LLC (Filed With SEC on August 5, 2021)

Patent License Agreement, effective as of December 22, 2014, by and between the Registrant and the Regents of the University of Michigan, as amended on March 3, 2015, July 22,... (Filed With SEC on February 24, 2021)

Master Collaboration Agreement, dated January 4, 2021 by and between the Registrant and Illumina, Inc (Filed With SEC on February 24, 2021)

Securities Purchase Agreement dated as of November 2, 2022 by and between Kura Oncology, Inc. and Bristol-Myers Squibb Company (Filed With SEC on November 3, 2022)

Form of Warrant Agreement issued by Kura Oncology, Inc. on November 2, 2022 to Hercules Capital, Inc. and certain other Lenders (Filed With SEC on November 3, 2022)

Sales Agreement, dated February 24, 2022, by and among Kura Oncology, Inc., SVB Securities LLC, Credit Suisse Securities (USA) LLC and Cantor Fitzgerald & Co (Filed With SEC on February 24, 2022)

Executive Employment Agreement, effective as of October 18, 2021, by and between the Registrant and Teresa Bair (Filed With SEC on February 24, 2022)

Form of International Restricted Stock Unit Award Grant Notice and International Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014... (Filed With SEC on February 24, 2022)

First Amendment to Amended and Restated Executive Employment Agreement, effective as of June 30, 2021, by and between the Registrant and Bridget Martell (Filed With SEC on August 5, 2021)

Executive Employment Agreement, effective as of February 10, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)

Executive Employment Agreement, effective as of January 6, 2020, by and between the Registrant and Kirsten Flowers (Filed With SEC on May 6, 2021)

Amendment to Executive Employment Agreement, effective as of February 22, 2021, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)

Amended and Restated Executive Employment Agreement, effective as of August 24, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)

Executive Employment Agreement, effective as of July 22, 2020, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on February 24, 2021)

Second Amendment to Executive Employment Agreement, effective as of February 19, 2021, by and between the Registrant and Troy E. Wilson, Ph.D., J.D (Filed With SEC on February 24, 2021)

Management Services Agreement, effective as of October 1, 2014, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)

Services Agreement, effective as of October 1, 2014, by and between the Registrant and Wellspring Biosciences, Inc (Filed With SEC on February 24, 2021)

Fifth Amendment to Patent License Agreement, effective as of May 24, 2017, by and between the Registrant and the Regents of the University of Michigan (Filed With SEC on February 24, 2021)

Amended and Restated Asset Purchase Agreement, dated February 12, 2015, by and between the Registrant and Araxes Pharma LLC (Filed With SEC on February 24, 2021)

License Agreement, dated December 18, 2014, by and between the Registrant and Janssen Pharmaceutica NV (Filed With SEC on February 24, 2021)

Underwriting Agreement, dated December 8, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC, Credit Suisse Securities (USA) LLC, Barclays Capital Inc., and Stifel, Nicolaus... (Filed With SEC on December 9, 2020)

Second Amendment to Office Lease Agreement, dated October 27, 2020 by and between the Registrant and BRE CA Office Owner LLC (Filed With SEC on November 5, 2020)

Form of International Stock Option Grant Notice, International Stock Option Agreement and International Notice of Exercise under the Kura Oncology, Inc. Amended and Restated... (Filed With SEC on November 5, 2020)

Amended and Restated Nonemployee Director Compensation Policy (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated May 5, 2020, by and among Kura Oncology, Inc., SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on May 6, 2020)

Separation Agreement, dated August 21, 2019, by and between the Registrant and John Farnam (Filed With SEC on May 4, 2020)

Executive Employment Agreement, effective as of November 4, 2019, by and between the Registrant and James Basta (Filed With SEC on May 4, 2020)

Office Lease Agreement, dated March 24, 2020, by and between the Registrant and East Office Operating Limited Partnership (Filed With SEC on May 4, 2020)

Second Amendment to Sublease, dated April 22, 2020 by and between the Registrant and Araxes Pharma LLC (Filed With SEC on May 4, 2020)

First Amendment to Office Lease Agreement, dated May 2, 2020 by and between the Registrant and BRE CA Office Owner LLC (Filed With SEC on May 4, 2020)

First Amendment to Loan and Security Agreement, dated April 3, 2020, by and between Kura Oncology, Inc. and Silicon Valley Bank (Filed With SEC on April 7, 2020)

Separation Agreement, dated February 5, 2020, by and between the Registrant and Antonio Gualberto, M.D., Ph.D (Filed With SEC on February 25, 2020)

Office Lease Agreement, dated January 8, 2020, by and between the Registrant and BRE CA Office Owners LLC (Filed With SEC on February 25, 2020)

Description of Registrants Common Stock (Filed With SEC on February 25, 2020)

Executive Employment Agreement, effective as of August 9, 2019, by and between the Registrant and Kathleen Ford (Filed With SEC on November 5, 2019)

First Amendment to Executive Employment Agreement, effective as of August 21, 2018, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on November 5, 2019)

Assignment and Assumption of Sublease, dated August 2, 2019, by and among the Registrant, Wellspring Biosciences, Inc. and Araxes Pharma LLC (Filed With SEC on November 5, 2019)

Underwriting Agreement, dated June 18, 2019, by and among Kura Oncology, Inc. and SVB Leerink LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 19, 2019)

Sales Agreement, dated March 5, 2019, by and among Kura Oncology, Inc., SVB Leerink LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on March 5, 2019)

First Amendment to Sublease, dated March 1, 2019, by and between the Registrant and Wellspring Biosciences, Inc (Filed With SEC on March 5, 2019)

Kura Oncology, Inc. (43)